DE LUCA, Arianna
 Distribuzione geografica
Continente #
NA - Nord America 2.977
AS - Asia 2.088
EU - Europa 1.462
SA - Sud America 604
AF - Africa 160
Continente sconosciuto - Info sul continente non disponibili 100
OC - Oceania 7
Totale 7.398
Nazione #
US - Stati Uniti d'America 2.835
SG - Singapore 817
BR - Brasile 450
CN - Cina 389
IT - Italia 381
VN - Vietnam 368
UA - Ucraina 302
DE - Germania 235
AT - Austria 120
FR - Francia 105
BD - Bangladesh 103
SE - Svezia 96
CA - Canada 80
IN - India 80
SN - Senegal 69
FI - Finlandia 61
HK - Hong Kong 58
AR - Argentina 52
TR - Turchia 48
KR - Corea 42
GB - Regno Unito 36
ZA - Sudafrica 35
IQ - Iraq 32
RU - Federazione Russa 29
MX - Messico 27
ID - Indonesia 25
PK - Pakistan 25
CO - Colombia 23
NL - Olanda 21
MA - Marocco 20
CL - Cile 16
EC - Ecuador 16
VE - Venezuela 16
BE - Belgio 14
JP - Giappone 13
PY - Paraguay 12
PL - Polonia 11
UZ - Uzbekistan 10
PH - Filippine 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
DZ - Algeria 8
ES - Italia 8
SA - Arabia Saudita 8
AU - Australia 7
EG - Egitto 7
LT - Lituania 7
TN - Tunisia 7
DO - Repubblica Dominicana 6
GT - Guatemala 6
PS - Palestinian Territory 6
AL - Albania 5
EU - Europa 5
MY - Malesia 5
TH - Thailandia 5
AZ - Azerbaigian 4
BH - Bahrain 4
BO - Bolivia 4
EE - Estonia 4
GE - Georgia 4
IL - Israele 4
KE - Kenya 4
KZ - Kazakistan 4
NP - Nepal 4
PE - Perù 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
CR - Costa Rica 3
GP - Guadalupe 3
IE - Irlanda 3
JM - Giamaica 3
BB - Barbados 2
BY - Bielorussia 2
BZ - Belize 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
ET - Etiopia 2
HN - Honduras 2
JO - Giordania 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
MU - Mauritius 2
NI - Nicaragua 2
RE - Reunion 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
FK - Isole Falkland (Malvinas) 1
GA - Gabon 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
IR - Iran 1
KW - Kuwait 1
Totale 7.294
Città #
Ashburn 389
Singapore 315
Chandler 308
San Jose 206
Council Bluffs 176
Dallas 164
Jacksonville 157
San Mateo 134
New York 120
Beijing 117
Ho Chi Minh City 115
Boardman 110
Rende 108
Hanoi 83
Vienna 81
Dakar 69
Dearborn 67
São Paulo 63
Milan 56
Hong Kong 53
Lawrence 47
Lauterbourg 46
Munich 46
Roxbury 46
Helsinki 45
Seoul 42
Shanghai 39
Chicago 33
Santa Clara 33
Ottawa 31
Rome 31
Brooklyn 28
Los Angeles 28
Izmir 27
Des Moines 26
Cambridge 24
Da Nang 22
Orem 19
Rio de Janeiro 19
Haiphong 18
Inglewood 17
Toronto 17
Wilmington 17
Phoenix 16
Turku 16
Bremen 15
Hefei 15
Brussels 14
Guangzhou 14
Hanover 14
Biên Hòa 13
Johannesburg 13
Ogden 13
Palermo 13
Pune 13
Seattle 13
London 12
Frankfurt am Main 11
Mexico City 11
Montreal 11
Salvador 11
Amsterdam 10
Columbus 10
Florence 10
Princeton 10
Tashkent 10
The Dalles 10
Tokyo 10
Ann Arbor 9
Baghdad 9
Falkenstein 9
Lahore 9
Montevideo 9
Belo Horizonte 8
Brasília 8
Guarulhos 8
Guayaquil 8
Hải Dương 8
Kansas City 8
Miano 8
Naples 8
Ninh Bình 8
Bogotá 7
Cosenza 7
Jakarta 7
Omaha 7
Recife 7
Casablanca 6
Groningen 6
Mumbai 6
Porto Alegre 6
Quito 6
Redwood City 6
San Francisco 6
Stockholm 6
Turin 6
Warsaw 6
Wuhan 6
Ankara 5
Atlanta 5
Totale 4.128
Nome #
17 β-estradiol activates GPER- and ESR1-dependent pathways inducing apoptosis in GC-2 cells, a mouse spermatocytes-derived cell line. 253
Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment 234
Activation of GPER inhibits growth of adrenocortical cancer (ACC) cells in vitro and in vivo suggesting a new the therapy for ACC 211
Estrogen related receptor a (ERRa) a promising target for the therapy of adrenocortical carcinoma (ACC) 209
A phenylacetamide resveratrol derivative exerts inhibitory effects on breast cancer cell growth 204
Activation of G-Protein-Coupled Estrogen Receptor (GPER) inhibits growth of adrenocortical cancer (ACC) cells in vitro and in vivo suggesting a new target for ACC treatment. 200
Adrenocortical Carcinoma (ACC) Cells Rewire Their Metabolism to Overcome Curcumin Antitumoral Effects Opening a Window of Opportunity to Improve Treatment 197
Cholesterol as an endogenous ERRα agonist: A new perspective to cancer treatment 194
Cyclooxygenase (Cox)-2 regulating transcriptional and post-transcriptional activation of aromatase is involved in Leydig cell tumor proliferation 187
Cholesterol as new target for ACC therapy. 185
A Resveratrol Phenylacetamide Derivative Perturbs the Cytoskeleton Dynamics Interfering with the Migration Potential in Breast Cancer 182
Activation of GPER inhibits growth of adrenocortical cancer (ACC) cells in vitro and in vivo suggesting a new the therapy for ACC 180
ERRα/PGC1α signaling pathway, which governs mitochondrial biogenesis, could represent a promising target for the therapy of adrenocortical carcinoma (ACC). 180
Antitumoral activities of curcumin and recent advances to improve its oral bioavailability 179
Cross talk of estrogen (E2) and IGF-II signalling in adrenocortical tumor cell proliferation. 168
GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo 161
Statins reduce intratumor cholesterol affecting adrenocortical cancer growth 155
Central role of estrogen receptor α in adrenocortical tumor cell proliferation. 151
SIRT1 is involved in adrenocortical cancer growth and motility 148
Role of GPER-Mediated Signaling in Testicular Functions and Tumorigenesis 147
XCT790 an inverse agonist of estrogen related receptor alpha (ERRalpha) inhibits cellular metabolism, motility and invasion of adrenocortical cancer cell line H295R. 146
Cross-talk between estrogen and IGF-II signalling in adrenocortical tumor cell proliferation. 143
Oleuropein and hydroxytyrosol activate GPER/ GPR30-dependent pathways leading to apoptosis of ER-negative SKBR3 breast cancer cells 140
Estrogen Related Receptor α (ERRα) A Promising Target for the Therapy of Adrenocortical Carcinoma (ACC). 140
Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers 140
Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells 138
The metabolic regulator estrogen-related receptor alpha as a therapeutic target in Adrenocortical Carcinoma (ACC). 136
Estrogen Related Receptor α (ERRα) As Potential Target for a New Adrenocortical Carcinoma (ACC) Therapy 131
GPER-independent inhibition of adrenocortical cancer growth by G-1 involves ROS/Egr-1/BAX pathway 131
Nandrolone and stanozolol induce Leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system 130
Oleuropeina ed idrossitirisolo attivano pathways GPER-dipendenti inducendo apoptosi in cellule tumorali mammarie SKBR3 negative per i recettori estrogenici α e β. 130
The novel estrogen receptor, G protein-coupled receptor 30, mediates the proliferative effects induced by 17β-estradiol on mouse spermatogonial GC-1 cell line 129
Estrogen Related Receptor Alpha (ERRα) a Bridge between Metabolism and Adrenocortical Cancer Progression 125
Involvment of Cyclooxygenase-2 (COX-2) in regulating estrogen-dependent Leydig cell tumor proliferation 124
Estrogen related receptor α(ERRα) a master regulator of reprogramming cancer cells metabolism as target to fight adrenocortical carcinoma (ACC) progression and as useful tool to determine ACC stem cell-like proprieties. 120
Mitotane activates GPER-dependent pathways leading to apoptosis of human adrenocortical carcinoma H295R cell line. 120
Estrogen related receptor α(ERRα) a master regulator of reprogramming cancer cells metabolism as target to inhibit growth and invasion of adrenocortical carcinoma (ACC) Università della Calabria 119
Inhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of leydig tumor cells 118
Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation 113
Role of ERRα in ACC as potential target for new adrenocortical cancer therapy. 109
The Involvement of Natural Polyphenols in Molecular Mechanisms Inducing Apoptosis in Tumor Cells: A Promising Adjuvant in Cancer Therapy 107
The novel estrogen receptor GRP30 mediates the proliferatiive effects induced by 17beta-estradiol onGC-1 mouse spermatogonial cell line 107
GPR30 mediates estradiol-proliferative effects on GC-1 mouse spermatogonial cell line through ERK/Fos activation 104
Oleuropein and hydroxytyrosol activates GPER-dependent pathways inducing apoptosis in ER-negative breast cancer cells SKBR3. 103
The Estrogen Related Receptor α (ERRα) inverse agonist XCT-790 reduces adrenocortical cancer (ACC) H295R cells growth in vitro and in vivo. 102
Role of scaffold protein Proline-, Glutamic acid-, and Leucine-Rich protein 1 (PELP1) in the modulation of adrenocortical cancer cell growth 102
The Novel Estrogen Receptor GPR30 Mediates the Proliferative Effects Induced by 17beta-Estradiol on GC-1 Mouse Spermatogonial Cell Line 98
Role of ERRα in ACC as potential target for new adrenocortical cancer therapy. 97
THE CENTRAL ROLE OF ESTROGEN RECEPTOR α IN IGF-II DEPENDENT ADRENOCORTICAL CARCINOMA (ACC) CELL PROLIFERATION SUGGESTS THE USE OF SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERMs) IN THE TREATMENT OF ACC. 91
Interactions between ERα, GPR30, EGFR and IGF1R and their role in controlling adrenocortical tumor cell proliferation 88
Beneficial Effects of Resveratrol on Testicular Functions: Focus on Its Antioxidant Properties 49
Simvastatin-Mediated Molecular Mechanisms Underlying the Growth Inhibition of Testicular Leydig Tumour Cells 43
Totale 7.398
Categoria #
all - tutte 38.198
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.198


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022522 0 0 0 43 79 8 7 140 11 10 76 148
2022/2023745 89 127 47 81 102 60 2 75 78 23 23 38
2023/2024480 45 21 25 38 30 140 17 16 40 24 10 74
2024/2025984 74 116 30 67 64 48 31 57 188 81 91 137
2025/20263.024 332 112 332 247 542 200 294 156 273 225 185 126
2026/2027764 154 54 126 430 0 0 0 0 0 0 0 0
Totale 7.398